1American Thoracic Society(ATS).ATS statement:standards for the diagnosis and care of patients with chronic obstructive pulmonary disease.Comprehensive outpatient management of COPD.Am J Respir Crit Care Med 1995;152:S86-96.
2Chapman KR.Therapeutic algorithm for chronic obstructive pulmonary disease.Am J Med 1991;91(4A):17S-23S.
3Ferguson GT.Cherniak RM.Management of chronic obstructive pulmonary disease.N Engl J Med 1993;328:1017-22.
4Anthonisen NR,Connett JE,Kiley JP,et al.Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV.The Lung Health Study.JAMA 1994;272:1497-505.
5Burchified CM,Marcus EB,Curb JD,et al.Effects of smoking and smoking cessation on (?) decline in pulmonary function.Am J Respir Crit Care Med 1995;151:1778-85.
6Dompeling E,van Schayck CP,van Grunsven PM,et al.Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids:a 4-year prospective study.Ann Intern Med 1993;118:770-8.
7Weiner P,Weiner M,Azgad Y,Zamir D.Inhaled budesonide therapy for patients with stable COPD.Chest 1995;108:1568-71.
9Ikeda A,Nishumura K,Koyama H,et al.Oxitropium bromide improves exercise performance in patients with COPD.Chest 1994;106:1740-5.
10Takasni T,Bevisi M,Patel H,et al.Effect of Ba 679 Br,a novel long acting anticholinergic agent on cholinergic neurotransmission in guinea pig and human airways.Am J Respir Crit Care Med 1994;150:1640-5.
